Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: A systematic review and meta-analysis

Journal of Surgical Research

Volumn 183, Issue 1, 2013, Pages 246-252

  McBride, Katherine ^a,b   McFadden, David ^a,b,c   Osler, Turner ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Pseudomyxoma peritonei

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; META ANALYSIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

EID: 84879116563     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.12.040     Document Type: Article

References (39)

1. M. Deraco, D. Baratti, and M.G. Inglese Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 2004 393
2. T.D. Yan, D. Black, R. Savady, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 2007 484
3. R.M. Smeenk, V.J. Verwaal, N. Antonini, and F.A.N. Zoetmulder Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 2007 104
4. D. Baratti, S. Kusamura, D. Nonaka, A.D. Cabras, B. Laterza, and M. Deraco Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy Ann Surg 249 2009 243
5. S. Alves, F. Mohamed, G. Yadegarfar, H. Youssef, and B.J. Moran Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Eur J Surg Oncol 36 2010 1156
6. T.C. Chua, A. Al-Zahrani, and A. Saxena Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 18 2011 1582
7. T.C. Chua, T.D. Yan, and M.E. Smigielski Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution Ann Surg Oncol 16 2009 1903
8. R.F. Bradley, J.H. Stewart, G.B. Russell, E.A. Levine, and K.R. Geisinger Pseudomyxoma Peritonei of Appendiceal Origin: a Clinopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review Am J Surg Pathol 30 2006 551
9. T.C. Chua, A. Al-Zahrani, and A. Saxena Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiaion J Am Coll Surg 211 2010 526
10. D. Baratti, S. Kusamura, and D. Nonaka Pseudomyxoma peritonei: clinical pathologic and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Ann Surg Oncol 15 2008 526
11. R.M. Smeenk, V.J. Verwaal, and F.A.N. Zoetmulder Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures Eur J Surg Oncol 32 2006 186
12. D. Baratti, S. Kusamura, and A. Martinetti Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 14 2007 2300
13. R.M. Smeenk, V.J. Verwaal, N. Antonini, and F.A.N. Zoetmulder Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome Ann Surg Oncol 14 2007 493
14. H. Youssef, C. Newman, K. Chandrakumaran, F. Mohamed, T.D. Cecil, and B.J. Moran Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin Dis Colon Rectum 54 2011 293
15. M. Deraco, S. Kusamura, and B. Laterza Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (hipec) in the treatment of pseudomyxoma peritonei: 10 years experience in a single center In vivo 20 2006 773
16. K.J. Zhu, and D.L. Morris Primary peritonectomy/HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures Surgeon 7 2009 345
17. T.C. Chua, W. Liauw, and A. Saxena Evolution of locoregional treatment for peritoneal carcinomatosis: a single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy Am J Surg 201 2011 149
18. Z.B. Qu, and L.X. Liu Management of pseudomyxoma peritonei World J Gastroenterol 12 2006 6124
19. O. Glehen, F. Mithieux, and D. Osinsky Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study J Clin Oncol 21 2003 799
20. S. Kusamura, R. Younan, and D. Baratti Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer 106 2006 1144
21. O. Sorenson, K. Flatmark, and W. Reed Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei Eur J Surg Oncol 38 2012 969
22. T.D. Yan, M. Links, Z.Y. Xu, P.C. Kam, D. Glenn, and D.L. Morris Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms Br J Surg 93 2006 1270
23. H. Andreasson, w Graf, P. Nygren, B. Glimelius, and H. Mahteme Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei Eur J Surg Oncol 38 2012 962
24. M. De Simone, M. Vaira, and A. Caponi Ten Years Experience in the Treatment of Pseudomyxoma peritonei by cytoreduction, peritonectomy, and semi-closed hyperthermic antiblastic peritoneal perfusion In vivo 20 2006 725
25. T.C. Chua, W. Liauw, and D.L. Morris Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome Int J Colorectal Dis 27 2011 381
26. T. Kitai, M. Kawashima, and K. Yamanka Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals Surg Today 41 2011 1219
27. D. Elias, F. Gilly, and F. Quenet Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy Eur J Surg Oncol 36 2010 456
28. T. Cioppa, M. Vaira, C. Bing, S. D'Amico, A. Bruscino, and M. De Simone Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei World J Gastroenterol 14 2008 6817
29. D. Elias, C. Honoré, and R. Ciuchendéa Peritoneal pseudomyxoma: results of systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Br J Surg 95 2008 1164
30. Z. Güner, U. Schmidt, M.H. Dahlke, H.J. Schlitt, J. Klempnauer, and P. Piso Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Int J Colorectal Dis 20 2005 155
31. T.J. Miner, J. Shia, D.P. Jaques, D.S. Klimstra, M.F. Brennan, and D.G. Coit Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 2005 300
32. F. Alexander-Sefre, K. Chandrakurmaran, and S. Banerjee Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence Colorectal Dis 7 2005 382
33. M. Deraco, M. De Simone, and C.R. Rossi An Italian Multicentric Phase II Study on Peritonectomy and Intra Peritoneal Hyperthermic Perfusion (IPHP) to treat patients with pseudomyxoma peritonei J Exp Clin Cancer Res 22 2003 35
34. S.A. Butterworth, O. Neely, M. Panton, D.J. Klaassen, A.M. Shah, and G.I. McGregor Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei Am J Surg 183 2002 529
35. A. Saxena, T.D. Yan, T.C. Chua, and D.L. Morris Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 17 2010 1291
36. A.J. Witkamp, E. de Bree, and M.M. Kaag Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei Br J Surg 88 2001 458
37. T.C. Chua, K. Al-Mohaimeed, W. Liauw, and D.L. Morris Pseudomyxoma peritonei: a need to establish evidence-based standard of care-is this the right trial? Ann Surg Oncol 16 2009 2675
38. T.C. Chua, W. Liauw, J. Zhao, and D.L. Morris Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate Ann Surg 253 2011 769
39. O. Glehen, F.N. Gilly, and F. Boutitie Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy Cancer 116 2010 5608